Sunscreen's Secret Bonus: It Could Help Keep You Cool

THURSDAY, April 11, 2019 -- Sunscreen may do double duty when you're outside on a summer day, keeping you cool as it protects your skin from the sun's harmful rays.

New research suggests how: When unprotected skin is exposed to the sun's ultraviolet (UV) rays, skin cells typically see a drop in levels of nitric oxide. This compound helps the skin's small blood vessels to relax and widen.

Drug Combo Does Double Duty Against Common Skin Lesions, Cancers

THURSDAY, March 21, 2019 -- Tens of millions of Americans develop sun-linked skin lesions called actinic keratoses, which are tied to later cancer risk.

Many will get a combo of treatments to help clear the blemishes.

When You Need to See a Dermatologist

FRIDAY, March 29, 2019 -- You might think of seeing a skin specialist for cosmetic procedures, to freshen skin or to get rid of lines. But do you recognize the signs of problems that need the attention of a skin doctor?

Here are some of the most common skin conditions and their warning signs.

Acne Drug Accutane May Not Depress Mood After All

MONDAY, March 4, 2019 -- For years, doctors have debated the safety of the acne drug most commonly known as Accutane, but new research suggests the medication does not boost depression risk among its users.

"The existing literature to date is quite mixed with regards to the issue of whether there is or is not an association between isotretinoin [Accutane] use and increased risk of depression," explained study author Dr. Bethanee Schlosser.

FDA Aims to Strengthen Sunscreen Rules

THURSDAY, Feb. 21, 2019 -- The U.S. Food and Drug Administration took steps Thursday to tighten regulation of over-the-counter sunscreen products.

Included in the proposed rule are updates on sunscreen safety, sun protection factor (SPF) requirements, and the effectiveness of insect repellent/sunscreen combinations.

Single Dose of Keytruda May Help Put Melanoma Into Remission

TUESDAY, Feb. 26, 2019 -- For people with the deadly skin cancer melanoma, one dose of the drug Keytruda before surgery might stop the cancer in its tracks, according to a groundbreaking new study.

Keytruda (pembrolizumab) is a PD-1 inhibitor, an immunotherapy drug that triggers the body's immune response to attack cancer cells. According to results of this study, the drug's effects peak as early as seven days after treatment -- much earlier than previously seen in other studies.